Skip to main content

Published locations for Panel Recommends Tofacitinib Approval for Refractory RA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Panel Recommends Tofacitinib Approval for Refractory RA

User login

  • Reset your password
  • /content/panel-recommends-tofacitinib-approval-refractory-ra
  • /edermatologynews/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /familypracticenews/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /internalmedicinenews/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /rheumatologynews/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /oncologypractice/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /hematology-oncology/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /rheumatology/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /internalmedicine/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /dermatology/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /familymedicine/article/54441/rheumatology/panel-recommends-tofacitinib-approval-refractory-ra
  • /dermatology/psoriasiscollection/article/54441/rheumatology/panel-recommends-tofacitinib-approval